BridgeBio Pharma LLC

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ Neil Kumar, Chief Executive Officer of BridgeBio Pharma LLC
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by BridgeBio Pharma LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Oncology Therapeutics, Inc. 10%+ Owner Common Stock 14,589,846 $156,363,757 $10.72 10 Oct 2025 Direct

Insider Reports Filed by BridgeBio Pharma LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BBOT BridgeBio Oncology Therapeutics, Inc. 10 Oct 2025 1 $0 4 10%+ Owner 16 Oct 2025, 17:54
BBOT BridgeBio Oncology Therapeutics, Inc. 11 Aug 2025 0 $0 3 10%+ Owner 18 Aug 2025, 17:16